Scimplify raises $19M Series C, doubles valuation to $245M
What's the deal? Specialty chemicals startup Scimplify is set to raise Rs 181 crore ($19.05 million) in a Series C round led by Hitachi VenturesDealroom has a profile for this one. Try Dealroom →, the corporate venture arm of Japan's Hitachi. Existing backers 3one4 CapitalDealroom has a profile for this one. Try Dealroom →, Accel, Omnivore PartnersDealroom has a profile for this one. Try Dealroom →, and Bertelsmann Nederland are also joining.
Who's putting in what? Hitachi Ventures will invest Rs 76.15 crore, followed by 3one4 Capital at Rs 31.41 crore. Accel, Omnivore Partners, and Bertelsmann Nederland will contribute Rs 28 crore, Rs 24.55 crore, and Rs 20.75 crore, respectively.
Why now? The round lands within a year of Scimplify's $40 million Series B, led by Accel in August 2025. The board passed a special resolution to issue 12,647 compulsorily convertible preference shares at Rs 1,43,012 each, according to regulatory filings.
What's the valuation? The deal values Scimplify at roughly Rs 2,323 crore ($245 million), up 114% from about Rs 1,086 crore ($128 million) previously. After the allotment, 3one4 Capital remains the largest external shareholder at 15.54%, with Accel at 13.84%; Hitachi Ventures will hold 3.28%.
What's the endgame? Founded in 2023 by Salil Srivastava and Sachin Santhosh, Scimplify helps enterprises develop, manufacture, and source specialty chemicals. Its platform serves pharmaceuticals, agrochemicals, personal care, and other industrial sectors through a network of manufacturing partners. Proceeds will fund business expansion and general corporate purposes.
By the numbers: Scimplify has yet to file FY26 financials. In FY25, operating revenue jumped more than 11X to Rs 200 crore from Rs 17.74 crore a year earlier, while losses widened to Rs 25.38 crore.
The signal: Hitachi Ventures leading a fast-follow round — barely a year after Accel's Series B — signals strategic corporate interest in Scimplify's manufacturing network as global buyers seek alternatives in specialty chemicals sourcing.
Read more: Entrackr
Image credit: U.S. Army Combat Capabilities Development Command
